115 related articles for article (PubMed ID: 7679585)
1. Acute myeloid leukaemia in the elderly: biology and treatment.
Johnson PR; Liu Yin JA
Br J Haematol; 1993 Jan; 83(1):1-6. PubMed ID: 7679585
[No Abstract] [Full Text] [Related]
2. Mitozantrone and cytosine arabinoside as first line therapy in elderly patients with acute myeloid leukaemia. Trent Working Party on Adult Leukaemia.
Hutchinson RM; Winfield DA
Br J Haematol; 1992 Mar; 80(3):416-7. PubMed ID: 1581225
[No Abstract] [Full Text] [Related]
3. SAB--a promising new treatment to improve remission rates in AML in the elderly?
Wheatley K
Br J Haematol; 2002 Aug; 118(2):432-3. PubMed ID: 12139727
[TBL] [Abstract][Full Text] [Related]
4. Intensive induction chemotherapy in elderly patients. The BGMT Group.
Reiffers J; Huguet F; Stoppa AM; Michallet M; Hurteloup P
Br J Haematol; 1992 Sep; 82(1):175-6. PubMed ID: 1419794
[No Abstract] [Full Text] [Related]
5. Fludarabine, cytarabine and topotecan (FLAT) as induction therapy for acute myeloid leukemia in the elderly: a preliminary report.
Leoni F; Ciolli S; Nozzoli C; Santini V; Fanci R; Rossi Ferrini P
Haematologica; 2001 Jan; 86(1):104. PubMed ID: 11146581
[No Abstract] [Full Text] [Related]
6. Double intensive consolidation chemotherapy in adult acute myeloid leukemia.
Harousseau JL; Milpied N; Briere J; Desablens B; Leprise PY; Ifrah N; Gandhour B; Casassus P
Semin Hematol; 1991 Jul; 28(3 Suppl 4):80-3. PubMed ID: 1780758
[No Abstract] [Full Text] [Related]
7. [The current chemotherapy of acute myeloid leukemias in adults].
Poddubnaia IV; Perilov AA
Ter Arkh; 1993; 65(7):86-9. PubMed ID: 8211791
[No Abstract] [Full Text] [Related]
8. GM-IVA, a short induction course for de novo acute myeloid leukemia, suitable for the elderly.
Pierri I; Clavio M; Miglino M; Cavaliere M; Pietrasanta D; Gobbi M
Haematologica; 1999 Jun; 84(6):562-3. PubMed ID: 10366806
[No Abstract] [Full Text] [Related]
9. "3+7" therapy for the treatment of acute myeloid leukemia. PRO.
Schiffer CA
Clin Adv Hematol Oncol; 2005 Feb; 3(2):127-9. PubMed ID: 16166981
[No Abstract] [Full Text] [Related]
10. Prognostic significance of risk group stratification in elderly patients with acute myeloid leukaemia.
Manoharan A
Br J Haematol; 2002 Aug; 118(2):683. PubMed ID: 12139766
[No Abstract] [Full Text] [Related]
11. Gemtuzumab ozogamicin with cytarabine and mitoxantrone as a third-line treatment in a poor prognosis group of adult acute myeloid leukemia patients: a single-center experience.
Specchia G; Pastore D; Carluccio P; Spinosa G; Giannoccaro M; Rizzi R; Mestice A; Liso V
Ann Hematol; 2007 Jun; 86(6):425-8. PubMed ID: 17364181
[TBL] [Abstract][Full Text] [Related]
12. [Controversies in the treatment of acute myeloid leukemia of the adult. Chemotherapy vs bone marrow transplantation].
Tartas N; Grassi D
Medicina (B Aires); 1991; 51(4):361-4. PubMed ID: 1821928
[No Abstract] [Full Text] [Related]
13. Therapy for elderly patients with acute myeloid leukemia: a problem in search of solutions.
Kantarjian HM
Cancer; 2007 Mar; 109(6):1007-10. PubMed ID: 17279580
[No Abstract] [Full Text] [Related]
14. New agents in the treatment of acute myeloid leukemia.
Wiernik PH
Semin Hematol; 1991 Jul; 28(3 Suppl 4):95-8. PubMed ID: 1780763
[No Abstract] [Full Text] [Related]
15. Factors associated with early reinduction chemotherapy for adults with acute myeloid leukemia.
Ueda M; Xie H; Sandhu RK; Walter RB; Pagel JM; Estey EH
Leuk Lymphoma; 2015 Mar; 56(3):782-4. PubMed ID: 24882254
[No Abstract] [Full Text] [Related]
16. The association of topotecan and cytarabine in the treatment of secondary or relapsed acute myeloid leukemia.
Pagano L; Mele L; Voso MT; Chiusolo P; Putzulu R; Mazzotta S; Leone G
Haematologica; 2001 Apr; 86(4):440-1. PubMed ID: 11325656
[TBL] [Abstract][Full Text] [Related]
17. [The therapeutic results in acute myeloid leukemias in elderly patients].
Parovichnikova EN; Savchenko VG; Isaev VG; Tikhonova LIu; Sarycheva TG; Kulikov SM
Ter Arkh; 1992; 64(8):87-9. PubMed ID: 1440406
[No Abstract] [Full Text] [Related]
18. Induction chemotherapy versus palliative treatment for acute myeloid leukemia in a consecutive cohort of elderly patients.
Colovic M; Colovic N; Radojkovic M; Stanisavljevic D; Kraguljac N; Jankovic G; Tomin D; Suvajdzic N; Vidovic A; Atkinson HD
Ann Hematol; 2012 Sep; 91(9):1363-70. PubMed ID: 22592651
[TBL] [Abstract][Full Text] [Related]
19. Improved cure rate by very early intensification combined with prolonged maintenance chemotherapy in patients with acute myeloid leukemia: data from the AML Cooperative Group.
Büchner T; Hiddemann W; Löffler G; Gassmann W; Maschmeyer G; Heit W; Hossfeld D; Weh H; Ludwig WD; Thiel E
Semin Hematol; 1991 Jul; 28(3 Suppl 4):76-9. PubMed ID: 1780757
[No Abstract] [Full Text] [Related]
20. Mitozantrone and cytosine arabinoside as first-line therapy in elderly patients with acute myeloid leukaemia.
Liu Yin JA; Johnson PR; Davies JM; Flanagan NG; Gorst DW; Lewis MJ
Br J Haematol; 1991 Nov; 79(3):415-20. PubMed ID: 1751369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
